|
(BS114) |
Loss of ceramide synthase 5 reduces the development of aortic valve stenosis in mice on high fat / high cholesterol diet |
| |
|
L. Reese, S. T. Niepmann, P. Düsing, L. Hänschke, S. Zimmer, G. Nickenig, R. Bauer, F. Jansen, A. Zietzer (Bonn) |
|
(BS115) |
The effect of protein oxidation in the development of heart failure with preserved ejection fraction (HFpEF) patients |
| |
|
S. Delalat, M. Jarkas, M. Tangos, H. Budde, N. Hamdani, for the study group: IFL (Bochum) |
|
(BS116) |
Oxidation of myofilament proteins in hypertrophic cardiomyopathy contributes to cardiomyocyte dysfunction |
| |
|
H. Budde, R. Hassoun, M. Herwig, M. Tangos, M. Begovic, M. Sieme, S. Delalat, L. van Heerebeek, A. Mügge, N. Hamdani, für die Studiengruppe: AG13 (Bochum; Amsterdam, NL) |
|
(BS117) |
Altered protein quality control system and inflammatory signaling pathways in atrial fibrillation patients |
| |
|
I. Sultana, M. Sieme, M. Herwig, M. Varatnitskaya, M. Tangos, S. Pabel, A. Mügge, S. T. Sossalla, N. Hamdani, für die Studiengruppe: IFL (Bochum, Regensburg) |
|
(BS118) |
Targeting PGE2 to treat sepsis-induced acute heart failure |
| |
|
R. Schell, B. Niehaus, N. Frey, J. Backs (Heidelberg) |
|
(BS119) |
Pro-inflammatory and remodeling-related miRNAs are differently regulated in male and female mice with chronic CVB3 myocarditis |
| |
|
M. O. Estepa Martinez, M. Niehues, N. Haritonow, U. Müller-Werdan, Y. Ladilov, V. Regitz-Zagrosek, M. L. Barcena (Berlin, Bernau) |
|
(BS120) |
Ceramides accumulate in aortic valve tissue of calcific aortic valve disease patients and accelerate valve calcification via NLRP3 inflammasome activation |
| |
|
E. Rawish, T. Rusack, J. Inderhees, M. Schneider, T. Stiermaier, I. Eitel, T. Schmidt, C. Frerker (Lübeck) |
|
(BS121) |
The CX3CL1 / CX3CXR1 axis regulates neutrophil heart tissue infiltration after myocardial infarction |
| |
|
S. Grell, E. Klapproth, P. Klose, K. Lorenz, A. El-Armouche (Dresden, Würzburg) |
